
EBE-A22
CAS No. 229476-53-3
EBE-A22( EBE-A22 | EBE A22 | EBEA22 )
Catalog No. M17448 CAS No. 229476-53-3
EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 49 | In Stock |
![]() ![]() |
5MG | 76 | In Stock |
![]() ![]() |
10MG | 106 | In Stock |
![]() ![]() |
25MG | 215 | In Stock |
![]() ![]() |
50MG | 327 | In Stock |
![]() ![]() |
100MG | 492 | In Stock |
![]() ![]() |
500MG | 1053 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameEBE-A22
-
NoteResearch use only, not for human use.
-
Brief DescriptionEBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
-
DescriptionEBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents. EBE-A22 unwinds supercoiled plasmid, stabilizes duplex DNA against heat denaturation, and produces negative CD and ELD signals, as expected for an intercalating agent. EBE-A22, but not PD153035, interacts preferentially with GC-rich sequences and discriminates against homooligomeric runs of A and T which are often cut more readily by the enzyme in the presence of the drug compared to the control.
-
In Vitro——
-
In Vivo——
-
SynonymsEBE-A22 | EBE A22 | EBEA22
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorEGFR/ErbB1
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number229476-53-3
-
Formula Weight374.23
-
Molecular FormulaC17H16BrN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 133.61 mM; H2O : < 0.1 mg/mL
-
SMILESCN(c1cc(ccc1)Br)c1ncnc2cc(c(cc12)OC)OC
-
Chemical NameN-(3-bromophenyl)-6,7-dimethoxy-N-methylquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goossens JF, et al. DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue. Biochemistry. 2001 Apr 17;40(15):4663-71.
molnova catalog



related products
-
FGFR2-IN-2
FGFR2-IN-2 is a specific FGFR2 inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used in the study of cancer and cardiovascular disease.
-
BLU9931
BLU9931 (BLU-9931) is a potent, selective, irreversible inhibitor of FGFR4 with IC50 of 3 nM.
-
Amlexanox
Amlexanox (AA673; CHX3673) is a specific inhibitor of IKKε and TBK1; inhibition of IKKε and TBK1 activity as determined by MBP phosphorylation showing an IC50 of approximately 1–2 μM.